Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Top Stories

Queue-jumping? Global vaccine shortage imperils Glasgow climate talks

Queue-jumping? Global vaccine shortage imperils Glasgow climate talks

Published : , on

By Laurie Goering

LONDON (Thomson Reuters Foundation) – Poorer nations struggling to access COVID-19 vaccines may make the “moral” choice not to send delegates to November’s U.N. climate summit in Scotland if others more in need of the doses remain at risk, climate and health experts warned on Wednesday.

Giving climate-talks delegates priority in vaccine-short countries would go against the principle of not “jumping the queue”, Dr. Ahmed Ogwell Ouma, deputy director of the Africa Centres for Disease Control and Prevention, told journalists in an online briefing.

Such a move could dim prospects for success at the high-profile COP26 climate conference, which aims to swiftly ramp up action on climate change as the world veers toward failing on its targets to curb dangerous planetary heating.

After negotiations were postponed in 2020, COP26 organisers hope to hold the key gathering in person – but the pandemic has complicated efforts to safely bring tens of thousands of delegates and observers from around the world to Glasgow.

Britain’s COP26 president, Alok Sharma, said last week that decisions had yet to be made about whether conference attendees must be vaccinated, but noted that “the safety of people in Glasgow and the UK, as well as delegates” was a priority.

If vaccines are required, Ogwell Ouma said African nations might decide delegates would not be “preferentially vaccinated” before others on national priority lists if supplies remained insufficient.

So far the continent has received just 38 million doses out of more than a billion distributed around the world – far too few for its population of more than a billion, he said.

That has left even healthcare workers and other highly vulnerable people without protection, he said, urging wealthy countries ahead of an upcoming G7 leaders’ summit in June to boost vaccine supplies for poorer nations.

Failing to do so could harm efforts to reach climate and other key international goals, he warned, noting “generosity is a strategic issue” for rich G7 nations.

Ulka Kelkar, climate programme director for the World Resources Institute in India, said with vaccines running short in her country amid a major COVID-19 surge, ensuring vaccine equity was “a fundamental test” of global ethics.

Ongoing battles over rights to technology and patents to produce COVID-19 vaccines have many parallels to the roadblocks in getting clean energy technology – and more climate finance – to developing nations, she added.

“The way we approach technology transfer now in this crisis … is a test of our values,” she said.

Tasneem Essop, executive director of Climate Action Network International, a civil society coalition, warned that if G7 governments did not agree to provide more vaccines and “a radical boost” in climate finance, “they can forget any deal in Glasgow”.

“We are looking for bold, moral and compassionate leadership” at the June G7 summit, also due to be held in Britain, said South Africa-based Essop.

She called the G7’s handling of the COVID-19 crisis “a dress rehearsal for how rich nations would address the climate crisis”.

Former British Prime Minister Gordon Brown, speaking in a video message, said G7 countries should provide two-thirds of the estimated $66 billion needed over two years to complete global vaccinations and deliver the U.N.-led COVAX programme to immunise the world’s poorest people.

“We require the richest countries to end any selfishness,” he said, noting the virus may continue to mutate and threaten even the already-vaccinated if immunisation efforts are not swiftly stepped up.

Spending more now to control the pandemic would be a good investment, he said, because “the value of the additional economic output is in the trillions” of dollars if global trade and movement resume.

(Reporting by Laurie Goering @lauriegoering; editing by Megan Rowling. Please credit the Thomson Reuters Foundation, the charitable arm of Thomson Reuters. Visit http://news.trust.org/climate)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post